Genetic deficiencies of both IL-4 receptor alpha chain and IL-10 trigger early onset of severe colitis in mice

A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals

(2023) Ke Wang et al.   Frontiers in Immunology

M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice

(2023) Alexandra M. Vlk et al.   mBio

Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease

(2022) Brunette Katsandegwaza et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease

(2021) Yaoyao Du et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1/M2 Macrophage Balance via the HIF-1α/glycolysis Pathway

(2021) Hongda Zhuang et al.   Frontiers in Immunology

Human interleukin-4–treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse model

(2020) Timothy S. Jayme et al.   Science Advances

Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells

(2019) S Sharba et al.   Virulence

YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis

(2019) Xin Zhou et al.   Cell Reports

IL-10 and IL-10 receptor defects in humans

(2012) Erik-Oliver Glocker et al.   Annals of the New York Academy of Sciences

Changes of the cytokine profile in inflammatory bowel diseases

(2012) Györgyi Műzes   WORLD JOURNAL OF GASTROENTEROLOGY

Colitis and Intestinal Inflammation in IL10−/− Mice Results From IL-13Rα2–Mediated Attenuation of IL-13 Activity

(2010) Mark S. Wilson et al.   GASTROENTEROLOGY